IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows Post author: Post published:December 14, 2023 Post category:uncategorized The role of type-2 interferon (IFNγ) in antiviral immunity. You Might Also Like Researchers develop magnetic nanoparticles for precise cancer treatment March 6, 2025 New comprehensive report on pediatric long COVID symptoms published February 12, 2024 Electroconvulsive therapy found to be highly effective in treating elderly patients with depression November 25, 2025
Electroconvulsive therapy found to be highly effective in treating elderly patients with depression November 25, 2025